• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

stark socioeconomic gaps in mental health care access across EU

Study reveals stark socioeconomic gaps in mental health care access across EU

Europe, mental health, 28 April 2025/in E-News, Mental health /by panglobal

New research highlights how financial barriers disproportionately affect lower-income Europeans seeking mental health support, with some countries showing alarming inequality ratios.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/mental_health_23.jpg 613 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-28 08:00:582025-04-23 09:41:31Study reveals stark socioeconomic gaps in mental health care access across EU
new type 5 diabetes formally recognised

Diabetes crisis deepens: 252 million unaware of condition as IDF recognises new type 5 diabetes

, 25 April 2025/in Diabetes, E-News /by panglobal

The International Diabetes Federation’s latest atlas reveals nearly one in nine adults globally now live with diabetes, while a new classification of malnutrition-related diabetes gains formal recognition.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/diabetes_23.jpg 641 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-25 08:00:592025-04-23 09:34:56Diabetes crisis deepens: 252 million unaware of condition as IDF recognises new type 5 diabetes
Antibiotics in infancy linked to higher asthma and food allergy risk

Antibiotics in infancy linked to higher asthma and food allergy risk

, 24 April 2025/in E-News, pharmacology, Research /by panglobal

A large-scale study from Rutgers Health has found that repeated antibiotic exposure in children under two years of age is associated with a significantly higher risk of developing asthma, food allergies and hay fever later in childhood. The research, involving over one million children, demonstrates that antibiotics may disrupt the digestive microbiome during a critical […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/antibiotics_24.jpg 640 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-24 07:30:392025-04-24 07:30:39Antibiotics in infancy linked to higher asthma and food allergy risk
Adolescent sleep patterns significantly impact cognitive ability

Adolescent sleep patterns significantly impact brain development and cognitive ability

, 24 April 2025/in Adolescent Health, E-News, Neurology /by panglobal

In a pioneering study examining the relationship between sleep patterns and adolescent brain development, researchers have revealed that young people who sleep longer and go to bed earlier show improved brain structure, neural connectivity, and cognitive performance compared to their peers with later bedtimes and shorter sleep duration – though even the best sleepers fall […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/sleep.jpg 759 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-24 07:17:582025-04-24 07:17:58Adolescent sleep patterns significantly impact brain development and cognitive ability
bacterial toxin exposure fuels young-onset colorectal cancer epidemic

Childhood bacterial toxin exposure fuels young-onset colorectal cancer epidemic

, 23 April 2025/in E-News, Oncology, Paediatrics /by panglobal

A bacterial toxin produced by certain strains of Escherichia coli may explain the alarming increase in colorectal cancer among young adults, according to groundbreaking research published in Nature. The study reveals that colibactin exposure in early childhood creates distinct genetic signatures that significantly increase cancer risk before age 50.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/colon_cancer_23.jpg 538 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-23 17:00:422025-04-23 09:27:48Childhood bacterial toxin exposure fuels young-onset colorectal cancer epidemic
tool for NASH diagnosis

AI tool for NASH diagnosis receives first EMA qualification

AIM NASH, 11 April 2025/in Diagnostic tests, E-News, Product News /by panglobal

The European Medicines Agency has qualified the first artificial intelligence-based tool designed to evaluate liver biopsies in patients with metabolic dysfunction-associated steatohepatitis (MASH). The system, called AIM-NASH, helps pathologists assess disease severity and reduce variability in histological scoring, with the aim of accelerating drug development for this increasingly common liver condition.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/liver.jpeg 518 922 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-11 08:00:212025-04-07 15:41:55AI tool for NASH diagnosis receives first EMA qualification
CNIO

Glutamate-triggered liver regeneration mechanism discovered

glutamate, liver, 10 April 2025/in E-News, Regenerative Medicine /by panglobal

New research reveals a rapid regenerative pathway activated minutes after liver injury through glutamate signalling between liver and bone marrow, offering potential therapeutic applications for liver damage.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/liver-regeneration-_-Nabil-Djouder.jpg 828 828 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-10 08:00:162025-04-07 15:30:58Glutamate-triggered liver regeneration mechanism discovered

Major cancer prevention report analyses world’s largest evidence base on dietary patterns

diet, 9 April 2025/in E-News, Oncology /by panglobal

A major new report by World Cancer Research Fund International provides strong evidence that following specific dietary and lifestyle patterns can significantly reduce cancer risk. The report, released 9 April, reviews 170 global studies and presents comprehensive recommendations based on patterns of eating, physical activity, and weight management rather than focusing on individual nutrients or […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/cancer_pink-ribbon.jpg 739 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-09 02:10:302025-04-07 15:20:13Major cancer prevention report analyses world’s largest evidence base on dietary patterns
(From left) Ph.D. candidate Museong Kim, Professor Jin Woo Kim, and Dr. Eun Jung Lee of KAIST Department of Biological Sciences

Novel gene therapy restores vision in mice by preventing Prox1 protein transfer

retina, 8 April 2025/in E-News, Regenerative Medicine /by panglobal

Korean researchers have developed a breakthrough gene therapy that restores vision loss caused by retinal degeneration. The therapy works by neutralising a protein called Prox1 that suppresses retinal regeneration. When the Prox1 protein is blocked, Müller glial cells in the retina can reprogram into stem-like cells that regenerate damaged neurons, restoring visual function.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/Retina-gene-therapy-photo-1.jpg 657 890 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-08 09:00:172025-04-07 15:11:00Novel gene therapy restores vision in mice by preventing Prox1 protein transfer
Billy Boyle, co-founder and CEO at Owlstone Medical

Cystic Fibrosis Foundation invests in Owlstone to develop breath test for Pseudomonas detection

, 8 April 2025/in Diagnostic tests, E-News /by panglobal

The Cystic Fibrosis Foundation has committed up to US$2.3 million (about £1.7 million) in equity investment to Owlstone Medical for the development of a breath test to detect Pseudomonas aeruginosa (PA) infections in people with cystic fibrosis (CF). The Cambridge-based company announced the investment on March 25, 2025, marking a significant step forward in respiratory […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/03/Billy-and-ReCIVA.jpg 667 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-08 08:00:422025-03-31 13:21:42Cystic Fibrosis Foundation invests in Owlstone to develop breath test for Pseudomonas detection
Page 5 of 232«‹34567›»

Latest issue of International Hospital

April 2024

11 July 2025

New Harley Street diagnostics clinic opens with the support of equipment and finance from Siemens

9 July 2025

New stem cell bank enables global Alzheimer’s research

9 July 2025

DNA-guided prescribing shows major clinical impact in NHS trial

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription